Syschem India (SYSCHEM) | Stock Overview & Key Data
Syschem India Performance Comparison
Stock Range
Today's Range
Low: ₹50.72
High: ₹57.90
on August 22, 2025
52 Week Range
Low: ₹35.33
High: ₹57.90
on April 7, 2025
on August 22, 2025
All-Time High: ₹149.00 on March 3, 2003
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR2.4B
EPS
0.46
P/E Ratio (TTM)
121.28
Forward P/E
N/A
P/B Ratio
2.51
PEG Ratio
0.10
Div. Yield
N/A
ROE
0.50%
Beta
-0.859
Debt to Equity
0.00
Financial Highlights
Profitability
Gross Margin
5.24%
Operating Margin
1.35%
Profit Margin
0.49%
Returns and Earnings
Return on Assets (TTM)
0.21%
Return on Equity (TTM)
0.50%
EBITDA
INR56.8M
Net Income (TTM)
INR20.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR94.42
Quarterly Revenue Growth (YoY)
24.10%
Quarterly Earnings Growth (YoY)
1,124.20%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Syschem India SYSCHEM | 2.43B Small-cap | 18.25% | 19.93% | 29.14% | 26.80% | 13.03% | 12.10% | 34.92% | 847.20% |
| Sun Pharmaceutical SUNPHARMA | 3.95T Large-cap | 0.56% | -2.16% | -4.47% | 0.14% | -13.13% | -7.54% | 86.54% | 195.42% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -0.21% | -6.98% | -5.91% | 7.87% | 1.29% | 26.68% | 71.47% | 87.96% |
| Sun Pharma Advanced SPARC | 47.41B Small-cap | 1.72% | -7.23% | -10.11% | 14.74% | -27.21% | -34.43% | -37.13% | -23.18% |
| Aarti Drugs AARTIDRUGS | 42.99B Small-cap | -4.13% | -10.00% | 1.76% | 27.10% | 6.05% | -14.34% | 10.27% | -34.08% |
| Sequent Scientific SEQUENT | 44.38B Small-cap | 0.12% | -6.92% | -2.35% | 12.64% | -4.77% | 5.41% | 52.52% | 30.60% |
Ownership & Short Interest
Insider Ownership
64.14%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
113K
Average 90-Day Volume
61K
Syschem India Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Syschem India would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SYSCHEM's 52-week high and low?
- In the last 52 weeks, Syschem India reached a high of ₹57.90 (on August 22, 2025) and a low of ₹35.33 (on April 7, 2025).
- What is the market cap and P/E ratio for SYSCHEM?
- Curious about Syschem India's size and valuation? Its market capitalization stands at 2.43B. When it comes to valuation, the P/E ratio (trailing twelve months) is 121.28, and the forward P/E (looking ahead) is N/A.
- Does SYSCHEM pay dividends? If so, what's the yield?
- As for dividends, Syschem India isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Syschem India's main competitors or similar companies to consider before investing?
When looking at Syschem India, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.95T Healthcare Drug Manufacturers - Specialty & Generic -7.54% 86.54% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 26.68% 71.47% Sun Pharma Advanced
SPARC47.41B Healthcare Drug Manufacturers - Specialty & Generic -34.43% -37.13% Aarti Drugs
AARTIDRUGS42.99B Healthcare Drug Manufacturers - Specialty & Generic -14.34% 10.27% Sequent Scientific
SEQUENT44.38B Healthcare Drug Manufacturers - Specialty & Generic 5.41% 52.52% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Syschem India Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Syschem India's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.50%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at 5.24%.
- What is the recent revenue and earnings growth for SYSCHEM?
- Looking at Syschem India's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 24.10%, and quarterly earnings saw a YoY growth of 1,124.20%.
- How much of SYSCHEM stock is held by insiders and institutions?
- Wondering who owns Syschem India stock? Company insiders (like executives and directors) hold about 64.14% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.